Welcome to Pharmaprojects’ 2017 review of trends in pharmaceutical R&D by Ian Lloyd, Senior Director of Pharmaprojects & Data Integration. This report assesses industry trends by examining the pipeline by company, therapeutic area, disease, target and drug type, using data from Pharma Intelligence’s Phamaprojects, which has been tracking global drug development since 1980. This report will be followed up by their annual supplement reviewing the New Active Substance launches for the year just past. But here, the focus is on research and development as it is now, how it is changing and mutating, and where it has been headed during 2016.

For the full report, please download the PDF version at the top of this page.

We are also offering the datapack behind this white paper here.